FUB-144
FUB-144 is an indole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug. It is an analogue of UR-144 and XLR-11 where the pentyl chain has been replaced with fluorobenzyl.In the United States, FUB-144 became a Schedule I Controlled Substance in 2019.
Sweden's public health agency suggested classifying FUB-144 as hazardous substance on March 24, 2015.
